More importantly, the new-scaffold AR ligands identified in this study could serve as a good starting point for further medicinal chemical studies such as structural modification, to facilitate the development of new drug candidates for PCa, muscle atrophy, osteoporosis, etc. This evidence concerns the gene AR and posterior cortical atrophy.